If we're lucky, we get old. Physical and mental decline are negative hallmark associations of aging. Imagine being born blind and, as you approach middle age, waking up with the ability to see. In this issue of PLOS Genetics, Cornils, Maurya, and colleagues discover such a phenomenon: age-related suppression of ciliogenesis defects [1] .
microtubule doublet region, whereas OSM-3 acts along to build the distal microtubule singlet region. In middle-aged IFT hypomorphic cilia, kinesin-II moves at a similar rate to that observed in healthy young adult cilia, whereas OSM-3 moves slower at kinesin-II rates, suggesting that kinesin-II but not OSM-3 driving ability is fully restored. Hypomorphic IFT-B and kinesin-II double mutants did not elongate cilia with age, whereas AdCR was observed in hypomorphic IFT-B and osm-3 double mutants. Based on these data, the authors conclude that AdCR is kinesin-II dependent but not OSM-3 dependent.
AdCR also restores sensory function to IFT-A and IFT-B hypomorphic animals. Severely sensory-deficient animals are now attracted to food sources and avoid harsh osmotic conditions, with increased ciliary length correlating with improved sensory function. Hence, AdCR restores ciliary structure, ciliary motor-based transport, and ciliary physiological functions.
The window of AdCR is further extended in long-lived daf-2 insulin receptor mutants, consistent with age dependence. In many animal species, reduced insulin signaling increases longevity via activation of the DAF-16/FOXO and HSF-1 transcription factors [10] . Loss of daf-16 has no impact on AdCR. However, hsf-1 and daf-21/HSP90 heat shock factors are required for AdCR and act cell autonomously. Heat stress does not induce AdCR, indicating that chronic stress is not responsible for revived cilia in aged IFT mutants.
From here, the authors go on to explore potential mechanisms driving AdCR and uncover a role for proteostasis and the ubiquitin-proteasome system (UPS) [11] . In vivo reporters of proteostasis and UPS activity indicate improved proteostasis and increased UPS activity in earlier stages of aging ciliated sensory neurons. Consistent with the UPS being a positive regulator of AdCR, pharmacological inhibition of UPS by bortezomib reduces AdCR.
Bortezomib treatment increases cilia length in wild-type animals, which is the only manipulation Cornils, Maurya, and colleagues found to have an effect in the presence of fully functional IFT machinery. Why UPS inhibition increases cilia length in healthy C. elegans but blocks AdCR in IFT mutants is unknown. The UPS has been implicated in multiple aspects of cilia biology [12] . For example, increased ubiquitination is observed in disassembling Chlamydomonas flagella [13] , and the ubiquitin conjugating system is found in both Chlamydomas flagellar and mammalian ciliary proteomes [14] . Future studies may provide insight to UPS action in healthy versus mutant cilia and in young versus old cilia.
The paper by Cornils, Maurya, and colleagues is a ground-breaking and pioneering study and opens up an entirely new and unexplored field in cilia cell biology. Moreover, several human ciliopathies are caused by non-null mutations (as null mutations are lethal) or by oligogenic interactions (reducing the function of two or more genes acting in a similar pathway). The authors propose that therapies relieving proteostatic stress may represent a form of personalized medicine for ciliopathy patients with specific mutations in IFT genes.
As with any exciting and unexpected finding, there are more questions than answers. Why is there a critical window for AdCR? What is the mechanism activating AdCR? Is AdCR evolutionarily conserved? Can AdCR be pharmacologically induced in patients? Are there other age-related health improvements and mechanisms yet to be discovered? Cornils, Maurya, and colleagues' report is encouraging: in some instances, aging can be beneficial.
